"Biological Products" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complex pharmaceutical substances, preparations, or matter derived from organisms usually obtained by biological methods or assay.
Descriptor ID |
D001688
|
MeSH Number(s) |
D20.215
|
Concept/Terms |
Biological Products- Biological Products
- Biologic Products
- Products, Biologic
- Biologics
- Products, Biological
|
Below are MeSH descriptors whose meaning is more general than "Biological Products".
Below are MeSH descriptors whose meaning is more specific than "Biological Products".
This graph shows the total number of publications written about "Biological Products" by people in this website by year, and whether "Biological Products" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2006 | 2 | 0 | 2 |
2007 | 2 | 0 | 2 |
2008 | 5 | 0 | 5 |
2009 | 1 | 0 | 1 |
2010 | 4 | 1 | 5 |
2011 | 2 | 1 | 3 |
2012 | 1 | 0 | 1 |
2013 | 2 | 1 | 3 |
2014 | 3 | 0 | 3 |
2015 | 3 | 0 | 3 |
2016 | 1 | 1 | 2 |
2017 | 2 | 2 | 4 |
2018 | 11 | 3 | 14 |
2019 | 7 | 4 | 11 |
2020 | 7 | 2 | 9 |
2021 | 12 | 2 | 14 |
2022 | 6 | 1 | 7 |
2023 | 14 | 0 | 14 |
2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biological Products" by people in Profiles.
-
Sequencing of Targeted Therapy in Psoriasis: Does it Matter? Am J Clin Dermatol. 2024 Sep; 25(5):795-810.
-
Real-World Outcomes of Dual Advanced Therapy in Children and Young Adults with Inflammatory Bowel Disease. Dig Dis Sci. 2024 May; 69(5):1826-1833.
-
PDGFRß Signaling Cooperates with ß-Catenin to Modulate c-Abl and Biologic Behavior of Desmoid-Type Fibromatosis. Clin Cancer Res. 2024 01 17; 30(2):450-461.
-
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study. J Crohns Colitis. 2023 Dec 30; 17(12):1897-1909.
-
Synthetically mannosylated antigens induce antigen-specific humoral tolerance and reduce anti-drug antibody responses to immunogenic biologics. Cell Rep Med. 2024 01 16; 5(1):101345.
-
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. Lancet Gastroenterol Hepatol. 2024 Feb; 9(2):133-146.
-
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease. Ann Med. 2023 12; 55(1):2198775.
-
Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval. J Ocul Pharmacol Ther. 2023 10; 39(8):572-582.
-
A Transplant or a Patch? A Review of the Biologic Integration of Meniscus Allograft Transplantation. JBJS Rev. 2023 09 01; 11(9).
-
A 13-year experience with biologic and biosynthetic absorbable mesh reinforced laparoscopic paraesophageal hernia repair. Surg Endosc. 2023 09; 37(9):7271-7279.